The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 27, 2018

Primary Completion Date

November 1, 2022

Study Completion Date

August 1, 2023

Conditions

Alcohol Use Disorder

Interventions

DRUG

Pregnenolone300

300mg

DRUG

Pregnenolone500

500mg

DRUG

Placebo

placebo

Trial Locations (2)

The Yale Stress Center: Yale University, New Haven

Yale Stress Center, New Haven

All Listed Sponsors

collaborator

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

NIH

lead

Yale University

OTHER

NCT03872128 - The Role of Neuroactive Steroids in Stress, Alcohol Craving and Alcohol Use in Alcohol Use Disorders | Biotech Hunter | Biotech Hunter